TOSYMRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tosymra, and what generic alternatives are available?
Tosymra is a drug marketed by Tonix Meds and is included in one NDA. There are eight patents protecting this drug.
This drug has ninety-one patent family members in twenty-nine countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tosymra
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on February 19th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOSYMRA?
- What are the global sales for TOSYMRA?
- What is Average Wholesale Price for TOSYMRA?
Summary for TOSYMRA
International Patents: | 91 |
US Patents: | 8 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Patent Applications: | 4,200 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TOSYMRA |
What excipients (inactive ingredients) are in TOSYMRA? | TOSYMRA excipients list |
DailyMed Link: | TOSYMRA at DailyMed |
![TOSYMRA drug patent expirations Drug patent expirations by year for TOSYMRA](/p/graph/s/t/TOSYMRA-patent-expirations.png)
![Drug Prices for TOSYMRA](/p/graph/drug-price/TOSYMRA.png)
Pharmacology for TOSYMRA
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
TOSYMRA is protected by eight US patents.
Patents protecting TOSYMRA
Formulations comprising triptan compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Formulations comprising triptan compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Alkylglycoside compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Formulations comprising triptan compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Formulations comprising triptan compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Formulations comprising triptan compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for TOSYMRA
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Galpharm Healthcare Ltd. | Sumatriptan Galpharm | sumatriptan | EMEA/H/C/002140 |
Refused | yes | no | no | 2012-02-09 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for TOSYMRA
See the table below for patents covering TOSYMRA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2012513412 | ⤷ Sign Up | |
Mexico | 2023002506 | FORMULACIONES DE EPINEFRINA INTRANASAL Y METODOS PARA EL TRATAMIENTO DE ENFERMEDADES. (INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE.) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2010075465 | ⤷ Sign Up | |
Hungary | E060917 | ⤷ Sign Up | |
China | 116549389 | 鼻内肾上腺素制剂及治疗疾病的方法 (Intranasal epinephrine formulations and methods of treating diseases) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |